Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy.
about
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccineAutophagy-associated immune responses and cancer immunotherapyThe Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A ReviewPathways and therapeutic targets in melanomaAutophagy, autophagy-associated adaptive immune responses and its role in hematologic malignanciesNanomaterials and autophagy: new insights in cancer treatmentCoupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated ImmunityCross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsPathways of antigen processing.Trial Watch: Toll-like receptor agonists in oncological indications.Trial watch: Immunostimulatory cytokines in cancer therapy.Therapeutic antitumor efficacy of B cells loaded with tumor-derived autophagasomes vaccine (DRibbles)Tumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent manner.HMGB1 in health and disease.Dendritic cell-based vaccines: barriers and opportunitiesAn autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation.Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma.Therapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer.Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.Ubiquitinated proteins enriched from tumor cells by a ubiquitin binding protein Vx3(A7) as a potent cancer vaccine.Of LAP, CUPS, and DRibbles - Unconventional Use of Autophagy Proteins for MHC Restricted Antigen PresentationAntigen Cross-Priming of Cell-Associated Proteins is Enhanced by Macroautophagy within the Antigen Donor Cell.Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High SpecificityTumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathway.Peptidases released by necrotic cells control CD8+ T cell cross-priming.Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5.Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression.The Autophagic Machinery in Viral Exocytosis.Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.Targeting the acute myeloid leukemic stem cell compartment by enhancing tumor cell-based vaccines.The impact of macroautophagy on CD8(+) T-cell-mediated antiviral immunity.Immunogenicity of necrotic cell death.Autophagy as a Stress Response Pathway in the Immune System.Autophagy proteins in antigen processing for presentation on MHC molecules.Dying cells actively regulate adaptive immune responses.TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles).Sorafenib and a novel immune therapy in lung metastasis from hepatocellular carcinoma following hepatectomy: A case report.Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.Immune responses of dendritic cells combined with tumor-derived autophagosome vaccine on hepatocellular carcinoma.Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs.
P2860
Q26748727-32E32E7E-C465-44F6-B22E-820C46D7C631Q26770690-330804B3-8B65-478E-9E27-515A4D0C1B72Q26782281-37C93090-1F00-481F-836F-D122236C50DEQ26865736-2F0B25BA-9613-4C5C-92D6-F867213FB275Q28072922-503C2F8A-569D-45BF-B792-82927A962EDBQ28386642-BF4F90B5-0BE6-4066-BB4D-3DB7740AD6BCQ28603015-5F5C5F2D-84AE-4CC4-BE81-87C1596F038CQ33613138-B8D6148F-2A9F-4DD3-9AE3-179D552C31B6Q33631854-DE558109-CBA2-4822-8250-A2CFFD420880Q33878578-6E035674-C341-43C8-B6AE-9B8476C4556FQ33880165-7787715A-74D0-409E-81C6-10D02CF12DDFQ34196895-3EA47B7F-751E-4375-B02A-480E56C5C80DQ34551535-621F44C4-E307-4854-AFB0-864CEDFB4D13Q34622835-8BA48223-3F91-4DCB-B684-E3E9C6671DC7Q34661797-7599E2F1-E56A-4D3F-9995-2DF993D4DBD7Q34995374-E808DAF6-0836-48CF-A133-7EB625CAD492Q35051335-D5D8A840-25C2-4B6A-A213-91256097984FQ35189742-AC504B7C-1987-466E-B664-BB4E73A31200Q35498335-DF9AC8E4-6C74-44B8-98EC-54BDCF65DF16Q35519862-8973EDEB-DF95-458C-81D2-4B8C04A5DF1BQ35550730-C74FF17C-42E1-4AD6-B697-8CDBB2B0D065Q35927584-23F9CB63-C54E-4912-AA80-383886C1AEF8Q36778316-3E13FED9-B4C7-492A-8E06-330899AFDCF2Q37222171-4832769C-CF0D-49A5-A153-64F279C09BDEQ37259198-A0165920-DF2D-4980-B43C-6A16624E44E1Q37299291-376724E0-B70F-49D4-BFBE-10B5AA122FC1Q37428061-BE5C1891-634A-4A32-B3C0-4031B3A0DA89Q37654915-256E97CA-7FC0-41D6-B83C-CA120FD9507AQ37707676-D457407E-FECB-4DC6-A6A1-36604B1DD54AQ38125532-72BF6F43-C27D-45E8-828B-AA8653EA5BBBQ38129080-A2ADA530-1A28-406E-A3B4-DF5F371A27F7Q38255959-D311CDF6-B183-4E24-98A7-2AA0DCA2BC74Q38362780-8DB5AC1B-88BB-429F-84DD-A48D8FC9E1DAQ38869705-E3F2441E-8F66-4753-99BD-7A9D653F1523Q38911753-0C530FF4-3504-4B02-A0D9-6DF8B088C41AQ39524777-C31E0E20-B0B7-4B53-B75E-7368C120CA89Q39572032-396E9129-EA16-4CD9-AEAA-69502214F25EQ40244514-E12CB408-1797-4199-A890-D4E95BA5857CQ40837686-C2552AE7-D80A-4658-BA26-8BCFA9B2CCF5Q41474629-AADC1A0A-3F51-4319-A8CC-2BC1EB025060
P2860
Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Tumor-derived autophagosome va ...... tion and therapeutic efficacy.
@ast
Tumor-derived autophagosome va ...... tion and therapeutic efficacy.
@en
type
label
Tumor-derived autophagosome va ...... tion and therapeutic efficacy.
@ast
Tumor-derived autophagosome va ...... tion and therapeutic efficacy.
@en
prefLabel
Tumor-derived autophagosome va ...... tion and therapeutic efficacy.
@ast
Tumor-derived autophagosome va ...... tion and therapeutic efficacy.
@en
P2093
P2860
P1476
Tumor-derived autophagosome va ...... tion and therapeutic efficacy.
@en
P2093
Bernard A Fox
Daniel Haley
Hong-Ming Hu
Li-Xin Wang
Puiyi Pang
Sandra Aung
Walter J Urba
Zhihua Cui
P2860
P304
P356
10.1158/1078-0432.CCR-11-0951
P407
P577
2011-11-08T00:00:00Z